Hoxton Financial’s Biogen BIIB Stock Holding History

Hoxton Financial’s Portfolio BIIB Stock Details BIIB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q1	$18K	Hold	70	–	–	0.01%	213
2015 Q4	$21K	Hold	70	–	–	0.01%	191
2015 Q3	$20K	Hold	70	–	–	0.01%	182
2015 Q2	$28K	Hold	70	–	–	0.01%	171
2015 Q1	$30K	Hold	70	–	–	0.01%	161
2014 Q4	$24K	Hold	70	–	–	0.01%	178
2014 Q3	$23K	Hold	70	–	–	0.01%	167
2014 Q2	$22K	Hold	70	–	–	0.01%	172
2014 Q1	$21K	Buy	+70	New	+$22.2K	0.01%	173

Other funds holding BIIB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Hoxton Financial's BIIB Position: Q1 2016 in Review

Hoxton Financial held its Biogen (BIIB) position steady in Q1 2016 at 70 shares worth $18K. The position accounts for 0.01% of the portfolio, ranked #213.

Hoxton Financial first reported a position in BIIB in Q1 2014 and has held it in 9 quarters since. The position peaked at $30K in Q1 2015. 948 funds tracked by Wall St. Rank hold BIIB as of Q1 2016.

Hoxton Financial held 70 shares of Biogen worth $18K as of Q1 2016.
Hoxton Financial left its Biogen share count unchanged in Q1 2016.
Biogen made up 0.01% of Hoxton Financial's portfolio in Q1 2016, its #213 holding.
Hoxton Financial first reported a position in Biogen in Q1 2014 and has held it in 9 quarters since.
Hoxton Financial's Biogen position peaked at $30K in Q1 2015.
948 funds tracked by Wall St. Rank held Biogen as of Q1 2016.

Based on Hoxton Financial's 13F filing for Q1 2016, filed 29 Apr 2016.